S
Skin+me
Health Tech & Medtech · London, United Kingdom · Founded 2019
Helping people to improve their lives through technology MoreLess
Skin + Me is a direct-to-consumer tele-dermatology company that provides personalized skincare solutions. The company's primary service is offering customized skincare treatments based on an online consultation. This digital-first approach allows customers to receive a diagnosis and a personalized treatment plan from a team of dermatologists and pharmacists without needing an in-person appointment.
The business model is subscription-based, where customers receive their prescribed treatments, which may include a combination of active ingredients like tretinoin, azelaic acid, and niacinamide, delivered to their homes on a recurring basis. This model ensures a steady revenue stream and fosters long-term customer relationships.
The company targets individuals with various skin concerns, including acne, hyperpigmentation, rosacea, and signs of aging. By offering a convenient and accessible alternative to traditional dermatology services, Skin + Me caters to a growing market of consumers seeking effective and personalized skincare.
Keywords: personalized skincare, dermatology, subscription service, direct-to-consumer, online consultation, acne treatment, anti-aging, rosacea treatment, hyperpigmentation treatment, skincare solutions
Talent graph
Skin+me's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Skin+me has talent and traffic
across markets
Market sentiment
What the market is saying about Skin+me
An AI-synthesized read of the highest-engagement posts about Skin+me on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Skin+me on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
